The indications of tautomeric conversion in amorphous bicalutamide drug.
Rams-Baron M, Wlodarczyk P, Dulski M, Wlodarczyk A, Kruk D, Rachocki A, Jachowicz R, Paluch M.
Rams-Baron M, et al. Among authors: wlodarczyk p, wlodarczyk a.
Eur J Pharm Sci. 2017 Dec 15;110:117-123. doi: 10.1016/j.ejps.2017.06.034. Epub 2017 Jun 28.
Eur J Pharm Sci. 2017.
PMID: 28666849
No abstract available.